Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence

August 8, 2022 updated by: University of Aarhus
The aim of this study is to investigate if a new irrigation system for transanal irrigation (TAI) is effective and more tolerable than the currently used system at the Pediatric Ward at Aarhus University Hospital.

Study Overview

Detailed Description

This is a randomized, controlled study.

This study will be performed at Aarhus University Hospital (Denmark) and Aalborg University Hospital (Denmark) following the same protocol.

According to the initial randomization, children will be allocated to treatment with the new system (group A) or with the currently used system (group B). After a period of 6 weeks the child will crossover to use the contrary system.

The hypothesis is that A TAI system specifically developed for children will enhance the child's toleration of irrigation due to fewer reports on pain at insertion which will lead to better compliance. This outcome will induce a comparable or better effect on their fecal incontinence and reduce the needed follow-up period due to fewer incontinence relapse.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Central Denmark Region
      • Aarhus, Central Denmark Region, Denmark, DK-8200
        • Aarhus University Hospital
    • The North Denmark Region
      • Aalborg, The North Denmark Region, Denmark, DK-9000
        • Aalborg University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Fecal incontinence on neurogenic or non-neurogenic basis, where transanal irrigation is indicated.

Exclusion Criteria:

  • Morbus Hirschsprungs disease.
  • Anorectal malformations.
  • Use of medication that are known to cause constipation (e.g. anticholinergics)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Newly developed cone for 6 weeks the currently used cone for 6 weeks
Starts off with treatment with the newly developed cone for transanal irrigation for 6 weeks and are then instructed to crossover to the contrary system, the currently used, for additional 6 weeks.
Newly developed cone in a softer material and a design matching the use for transanal irrigation.
Cone currently used for transanal irrigation at the Pediatric Ward, Aarhus University Hospital.
Active Comparator: Currently used cone for 6 weeks the newly developed cone for 6 weeks
Starts off with treatment with the currently used cone for transanal irrigation for 6 weeks and are then instructed to crossover to the contrary system, the currently used, for additional 6 weeks.
Newly developed cone in a softer material and a design matching the use for transanal irrigation.
Cone currently used for transanal irrigation at the Pediatric Ward, Aarhus University Hospital.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect on fecal incontinence episode frequency
Time Frame: 12 weeks
Evaluated by home recordings.
12 weeks
Evaluation of discomfort and on pain assessed on a Visual Analog Scale
Time Frame: 12 weeks
Evaluated by home recordings.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extent of constipation
Time Frame: 12 weeks
Evaluated by home recordings and transabdominal rectal ultra sound.
12 weeks
Evaluation of urinary incontinence episodes
Time Frame: 12 weeks
Evaluated by home recordings.
12 weeks
Evaluation of compliance assessment using the different systems
Time Frame: 12 weeks
Evaluated by home recordings.
12 weeks
Estimation in changes of the child's well-being
Time Frame: 12 weeks
Evaluated by home recordings using WHO-5
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2021

Primary Completion (Actual)

July 31, 2022

Study Completion (Actual)

July 31, 2022

Study Registration Dates

First Submitted

August 27, 2021

First Submitted That Met QC Criteria

August 27, 2021

First Posted (Actual)

September 2, 2021

Study Record Updates

Last Update Posted (Actual)

August 9, 2022

Last Update Submitted That Met QC Criteria

August 8, 2022

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fecal Incontinence

Clinical Trials on Cone Small, Qufora A/S

Subscribe